Literature DB >> 1740034

Case report: multiple hepatic and pulmonary haemangioblastomas--a new manifestation of von Hippel-Lindau disease.

F P McGrath1, R G Gibney, D C Morris, D A Owen, S R Erb.   

Abstract

Capillary haemangioblastomas rarely occur outside the central nervous system and have not been described previously in the lung or liver. We describe such lesions developing in a patient with von Hippel-Lindau complex who previously had cerebellar and spinal haemangioblastomas resected.

Entities:  

Mesh：

Year:  1992        PMID： 1740034     DOI： 10.1016/s0009-9260(05)81467-9

Source DB:  PubMed          Journal:  Clin Radiol        ISSN： 0009-9260            Impact factor:   2.350


  16 in total

1.  Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.

Authors:  Erinn B Rankin; Debra F Higgins; Jacqueline A Walisser; Randall S Johnson; Christopher A Bradfield; Volker H Haase
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

2.  Congenital extraneural hemangioblastoma in a lamb.

Authors:  Turan Yaman; Abdullah Karasu; Ahmet Uyar; Yağmur Kuşçu; Ömer Faruk Keleş
Journal:  J Vet Diagn Invest       Date:  2019-02-17       Impact factor: 1.279

Review 3.  The VHL tumor suppressor in development and disease: functional studies in mice by conditional gene targeting.

Authors:  Volker H Haase
Journal:  Semin Cell Dev Biol       Date:  2005-04-26       Impact factor: 7.727

4.  VHL and PTEN loss coordinate to promote mouse liver vascular lesions.

Authors:  Shufen Chen; Christie A Sanford; Junjiang Sun; Vivian Choi; Terry Van Dyke; R Jude Samulski; W Kimryn Rathmell
Journal:  Angiogenesis       Date:  2010-03-11       Impact factor: 9.596

Review 5.  Adrenal haemangioblastoma presenting as phaeochromocytoma: a rare manifestation of extraneural hemangioblastoma.

Authors:  Prabal Deb; Seerat Pal; Vibha Dutta; Anand Srivastava; Akshay Bhargava; Krishan Kumar Yadav
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

Review 6.  Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastoma.

Authors:  Stanley Park; Chi-Chao Chan
Journal:  Histol Histopathol       Date:  2012-08       Impact factor: 2.303

Review 7.  The VHL tumor suppressor and HIF: insights from genetic studies in mice.

Authors:  P P Kapitsinou; V H Haase
Journal:  Cell Death Differ       Date:  2008-01-25       Impact factor: 15.828

8.  Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice.

Authors:  Erinn B Rankin; Jennifer Rha; Travis L Unger; Chia H Wu; Heather P Shutt; Randall S Johnson; M Celeste Simon; Brian Keith; Volker H Haase
Journal:  Oncogene       Date:  2008-05-19       Impact factor: 9.867

Review 9.  The VHL tumor suppressor: master regulator of HIF.

Authors:  Volker H Haase
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

10.  Target chromosomes of inducible deletion by a Cre/inverted loxP system in mouse embryonic stem cells.

Authors:  Masako Tada; Hiroyuki Matsumura; Yuko Kurose; Norio Nakatsuji; Takashi Tada
Journal:  Chromosome Res       Date:  2009-03-31       Impact factor: 5.239
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.